ASCEND WELLNESS HOLDINGS, INC. Financials Ascend Wellness Holdings, Inc.
Equities
AAWH.U
US04351N1063
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.27 USD | -1.55% |
|
-0.78% | +30.93% |
| 13/03 | Ascend Wellness Holdings, Inc. Announces the Opening of its Third Medical Dispensary in Pennsylvania | CI |
| 12/03 | Transcript : Ascend Wellness Holdings, Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,145 | 217 | 200.7 | 274.3 | - | - |
| Enterprise Value (EV) 1 | 1,448 | 705.9 | 200.7 | 484.9 | 447.1 | 274.3 |
| P/E ratio | - | -2.61 x | -4.04 x | -5.58 x | -17.3 x | -9.77 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 3.45 x | 0.53 x | 0.39 x | 0.48 x | 0.44 x | 0.4 x |
| EV / Revenue | 4.36 x | 1.74 x | 0.39 x | 0.84 x | 0.72 x | 0.4 x |
| EV / EBITDA | 18.2 x | 7.57 x | 1.88 x | 3.9 x | 3.16 x | 1.82 x |
| EV / FCF | -11.1 x | -5.88 x | - | 12.4 x | 9.22 x | 7.03 x |
| FCF Yield | -8.99% | -17% | - | 8.04% | 10.8% | 14.2% |
| Price to Book | 6.43 x | 1.29 x | - | 2.89 x | 2.44 x | 2.82 x |
| Nbr of stocks (in thousands) | 1,73,248 | 1,88,662 | 2,06,871 | 2,12,674 | - | - |
| Reference price 2 | 6.610 | 1.150 | 0.9700 | 1.270 | 1.270 | 1.270 |
| Announcement Date | 08/03/22 | 14/03/23 | 12/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 143.7 | 332.4 | 405.9 | 518.6 | 577.1 | 617.1 | 678.2 |
| EBITDA 1 | - | 79.43 | 93.22 | 106.5 | 124.5 | 141.4 | 151 |
| EBIT 1 | - | -17.2 | -7.526 | -3.619 | 25.27 | - | - |
| Operating Margin | - | -5.18% | -1.85% | -0.7% | 4.38% | - | - |
| Earnings before Tax (EBT) 1 | - | - | -39.21 | -14.76 | -1.15 | - | - |
| Net income 1 | -25.44 | - | -80.9 | -48.21 | -31.78 | 31.4 | - |
| Net margin | -17.7% | - | -19.93% | -9.3% | -5.51% | 5.09% | - |
| EPS 2 | -0.1300 | - | -0.4400 | -0.2400 | -0.2275 | -0.0733 | -0.1300 |
| Free Cash Flow 1 | - | -130.2 | -120 | - | 39 | 48.5 | 39 |
| FCF margin | - | -39.16% | -29.56% | - | 6.76% | 7.86% | 5.75% |
| FCF Conversion (EBITDA) | - | - | - | - | 31.33% | 34.29% | 25.83% |
| FCF Conversion (Net income) | - | - | - | - | - | 154.46% | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 26/02/21 | 08/03/22 | 14/03/23 | 12/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 94.38 | 88.5 | 85.09 | 97.5 | 111.2 | 112.1 | 114.2 | 123 | 141.3 | 140.2 | 139.8 | 143.3 | 146.2 | 148.4 | 149.8 |
| EBITDA 1 | 23.53 | 19.76 | 16.37 | 20.89 | 27.77 | 28.19 | 23.31 | 21.32 | 29.52 | 32.35 | 29.84 | 30.56 | 31.95 | 32.3 | 32.45 |
| EBIT 1 | 11.61 | -0.731 | -14.78 | -0.605 | 2.477 | 5.382 | 0.255 | -7.985 | 3.547 | 0.564 | 7 | 8 | 10 | 8 | - |
| Operating Margin | 12.3% | -0.83% | -17.37% | -0.62% | 2.23% | 4.8% | 0.22% | -6.49% | 2.51% | 0.4% | 5.01% | 5.58% | 6.84% | 5.39% | - |
| Earnings before Tax (EBT) 1 | - | - | - | -9.7 | -5.684 | -3.114 | -8.455 | 5.578 | -4.514 | -7.369 | -2 | - | 2 | - | - |
| Net income 1 | - | - | - | -21.17 | -16.86 | -15.05 | -18.74 | 0.841 | -11.24 | -19.34 | -13.7 | -12.9 | -12.6 | -12.95 | - |
| Net margin | - | - | - | -21.72% | -15.16% | -13.43% | -16.42% | 0.68% | -7.96% | -13.8% | -9.8% | -9% | -8.62% | -8.73% | - |
| EPS 2 | -0.0800 | - | - | -0.1100 | -0.0900 | -0.0800 | -0.1000 | 0.004300 | -0.0500 | -0.0900 | -0.0650 | -0.0600 | -0.0550 | -0.0550 | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/11/21 | 08/03/22 | 11/05/22 | 15/08/22 | 10/11/22 | 14/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 12/03/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 303 | 489 | - | 211 | 173 | - |
| Net Cash position 1 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 3.818 x | 5.245 x | - | 1.692 x | 1.222 x | - |
| Free Cash Flow 1 | - | -130 | -120 | - | 39 | 48.5 | 39 |
| ROE (net income / shareholders' equity) | - | -76.4% | - | - | -27.9% | -5.1% | - |
| ROA (Net income/ Total Assets) | - | -12% | - | - | -0.75% | 8.2% | - |
| Assets 1 | - | - | - | - | 4,237 | 382.9 | - |
| Book Value Per Share 2 | - | 1.030 | 0.8900 | - | 0.4400 | 0.5200 | 0.4500 |
| Cash Flow per Share 2 | - | -0.2800 | -0.2100 | - | 0.1300 | 0.3800 | - |
| Capex 1 | - | 88.4 | 81.6 | - | 35 | 15 | 10 |
| Capex / Sales | - | 26.6% | 20.11% | - | 6.06% | 2.43% | 1.47% |
| Announcement Date | 26/02/21 | 08/03/22 | 14/03/23 | 12/03/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
1.29
USD
Average target price
3.406
USD
Spread / Average Target
+164.05%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +30.93% | 274M | |
| +47.74% | 275M | |
| +48.84% | 195M | |
| -14.29% | 145M | |
| +57.96% | 142M | |
| -31.21% | 141M | |
| +147.89% | 140M | |
| -7.69% | 80.05M | |
| +150.00% | 75.33M | |
| +43.75% | 66.15M |
- Stock Market
- Equities
- AAWH.U Stock
- Financials Ascend Wellness Holdings, Inc.
